Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Academic program of ADE
Case Report
Current Issue
Guest editorial
Original Article
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Academic program of ADE
Case Report
Current Issue
Guest editorial
Original Article
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Academic program of ADE
Case Report
Current Issue
Guest editorial
Original Article
Review Article
View/Download PDF

Translate this page into:

2 (
); 1-6

Interaction between Bone Cells in Bone Remodelling

Intern; Department Of Oral Pathology, Vinayaka Mission’s Sankarachariyar Dental College, NH-47, Sankari main road, Ariyanoor, Salem - 636308, Tamil Nadu, India, ,
Senior Lecturer, Department Of Oral Pathology, Vinayaka Mission’s Sankarachariyar Dental College, NH-47, Sankari main road, Ariyanoor, Salem - 636308, Tamil Nadu, India, ,
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
This article was originally published by Informatics Publishing and was migrated to Scientific Scholar after the change of Publisher.


Bone forms the basic framework of the body and it consists of bone cells, ground substance and collagen fibres. The bone undergoes alternate deposition and resorption to withstand the biomechanical forces exerted. Osteoclasts, osteoblasts, osteocytes secrete numerous enzymes, cytokines, growth factors which interact among one another to perform the physiological activities taking place in bone. This article emphasizes on the secretions of osteoblast that interacts with the osteoclast precursor involved in osteoclastic stimulation and inhibition and vice versa osteoclastic activity on bone can trigger osteoblastic formation or inhibition. This interaction is explained based on 3 different modes: Direct cell-cell contact, gap junctions, diffusion of paracrine factors and the 3 phases of bone remodelling.

1. Introduction

Bone is a rigid mineralized structure providing protection to vital organs, acts as a habitat for bone marrow and hematopoiesis, maintains acid – base balance and facilitates body movements. Bone is the mineral reservoir of calcium, phosphate, etc1.

Based on the pattern of collagen formation the bone can be classified as woven bone (irregularly organized collagen fibres) and the lamellar bone (alternating orientation of collagen fibres with significant mechanical strength). Osteoblast, osteoclast, lining cells and osteocytes are the bone cells involved in bone remodelling2.

2. Osteoblast

Osteoblast, commonly known as bone forming cells that are formed from the osteoprogenitor cells (mesenchymal stem cells). The osteoprogenitor cells undergo WNT (calcium) pathway or Bone Morphogenic Protein (BMP) pathway for the formation and differentiation of osteo-blast1. The mature osteoblasts are plump, cuboidal cells or flattened cells bearing the keys for the lock present in osteoclast precursors2.

The primary function of osteoblast is bone matrix formation. Osteoblast secretes products such as type I and type V collagen, proteoglycans and non-collagenous proteins such as sialoprotein and osteopontin3.

Osteoblasts bear receptors for the hormones like

Parathormone (PTH)

Parathormone releasing protein (PTHrP) 1,2

dihydroxy cholecalciferol (VIT – D) Calcitonin



Osteoblast secretes enzymes like alkaline phosphatase, pyrophosphatase etc. The interaction between osteoblast and hormones plays a major role in the formation and inhibition of osteoclast1. Alkaline phosphatase is called the osteoblast biomarker2. The role of osteoblasts such as bone formation, secretion of various enzymes, growth factors and regulations of osteoclasts comes to the end within the life span of 3 months, but still osteocytes (one of the end product of osteoblast and major component of bone architecture) have minor potential in secretion of certain proteins4,5.

Table 1. Secretions of osteoblast1
Cytokines Growth factors Enzymes
Interleukin (IL)- 1, IL-4, Bone Morphogenic Protein Alkaline phosphatase
IL-6, IL - 8, IL 11, IL 13. (BMP) – 2,4,6,7. Pyrophosphatase
Interferon Beta Transforming Growth Factor (TGF)
Prostaglandins Beta.
E1,E2,I2,H2, Insulin Growth Factor (IGF) - I, II
Osteoprotegrin Platelet Derived Growth Factor (PDGF)
RANKLigand Fibroblast growth factor (FGF)
Tumour necrosis factor (TNF)
Epidermal growth factor (EGF)

Normally in lamellar bone the collagen fibres are arranged in well organized manner but in some conditions like fibrous dysplasia, callus formation in bone fracture, hyperparathyroidism etc., the collagen fibres are arranged irregularly in a basket like weave array manner.

The mutations of growth factors are potential enough to cause multiple disorders. For eg: fibroblast growth factors are potential in altering the craniofacial skeleton such as Aperts Syndrome, Achondroplasia, Crouzons Syndrome6.

After the deposition of bone matrix the osteoblast has 4 fates: a) Become an osteocyte, b) Transformation into lining cells, c) Transdifferentiate into cells that deposit chondroid bone d) Undergo apoptosis5.

3. Osteocytes

Osteocytes are derived from osteoprogenitor osteocytes and it comprises the major cell count of bone. Osteocytes are relatively inert in nature. Osteocytes are stellate shaped with multiple cell process (40-60)7. These cell processes connect with adjacent osteocytes and osteoblasts and provide nutrition to bone and exchange of waste through gap junction thus maintaining the vitality of bone. Osteocytes help in transmission of signal over long distance. In the conversion of osteoblast to osteocyte three intermediate stages are seen. They are,

  • Type I preosteocyte.

  • Type II preosteocyte.

  • Type III preosteocyte8.

Osteocytes are said to be relatively inert because during the conversion of osteoblast to osteocyte, volume of osteoblast reduces by 70% .When osteocytes are destroyed bone resorption is induced and bone formation is decreased8,9. Inhibition of bone formation by osteocytes is done with the help of a protein called sclerostin. Sclerostin is inhibited by parathyroid hormone5.

Fate of osteocytes can occur as a result of apoptosis, necrosis, senescence or osteoclastic engulfment. Excess apoptosis can cause osteoporosis, osteoarthritis8,10.

4. Lining Cells

Lining cells are inactive osteoblasts that are flattened. These cells have 3 major functions:

  • Protects the bone from chemical substances that can eat away bone.

  • Acts as an immediate access to calcium when blood calcium level is low.

  • Helps in maintenance of bone fluids2,3.

5. Osteoclast

Osteoclasts are multinucleated giant cells which take part both in physiological as well as pathological resorption of bone. Osteoclast originates from the hematopoietic stem cells. Macrophage is believed to give rise for osteoclasts with the help of monocyte macrophage colony stimulating factor (M-CSF) and RANKL (Receptor Activator Of Nuclear Factor Kappa-B Ligand)1.

Osteoclasts are larger in dimension with multiple nuclei, abundant mitochondria and extensive golgi bodies. The osteoclasts can be functional or nonfunctional. The functional osteoclasts are polarized with three distinct domains such as ruffled border, functional secre-tory domain and a basolateral membrane whereas the non-functional osteoclast lacks polarization and different domains4.

Osteoclasts also contain Tartrate Resistant Acid Phosphatase (TRAP), calcitonin, vitronectin receptor and vacuolar proton Adenosine Tri phosphatase. Osteoclast exhibits terminal differentiation (i.e.,) unable to differentiate back to macrophage or any other cell11,12.

Osteoclasts have unique machinery for dissolving mineral within bone matrix. Osteoclast reaches the bone resorption site and secretes numerous integrin receptors like αvβ1, α2β1, αvβ3, αvβ5 which helps in cell to cell interaction and cell matrix migration. These integrin receptors are also involved in leukocyte activation and aggregation of tumour cells. Once osteoclast determines the site of activation, it binds to bone, gets polarized and forms ruffled borders which increases the surface area for resorption. The vitronectin part of the osteoclast gets attached to the bone and is called the sealing zone. The resorbed area is irregular which forms the resorption lacunae.

The study conducted by Lakkakorpi et al 1991 failed to demonstrate the presence of sealing zone where as Vannen and Horton in 1995 hypothetized the plasma membrane attached tightly to the bone by sealing zone12.

The main function of osteoclast is resorption of mineralized bone matrix by dissolution of hydroxyapatite crystal and cleavage of organic matrix. Before the collagen rich organic matrix gets degraded, the hydroxyapatite crystal has to be degraded. Most accepted way of dissolution of mineral occurs by secretion of HCl through ruffled borders. Area of low pH seen in the resorption lacunae is attained by (ATP) proton pumps. The number of intracellular acidic compartments decreases as the vesicles containing proton pumps are transported to the ruffled borders13.

Osteoclast secretes several proteolytic enzymes like lysosomal cysteine proteinases, matrixmetalloproteinase, cathepsin K etc., that degrades the organic matrix in the resorption lacunae. Matrix metalloproteinase is a key player in the resorption of organic matrix. The role of Cathepsin K in the resorption process is explained with the study on osteopetrotic mice. Cathepsin K is a serine theorine protease that can sever type I collagen the major component of bone matrix.

6.Mechanism of Interaction between Osteoblast and Osteoclast can be, Direct cell – Cell Contact

The intercellular signaling occurs through membrane bound ligands. Direct cell to cell contact occurs through RANK Ligand/RANK interaction and Ephrin signaling.

  • RANK Ligand/RANK Interaction:

  • RANK Ligand interacts with RANK on the surface of osteoclast precursors for differentiation of osteoclast.

  • Ephrin/ Eph signaling: It is a bidirectional signaling between osteoblast and osteoclasts.

Ephrin B2, a ligand expressed by osteoclast precursor suppresses osteoclast differentiation.

Ephrin B4 in osteoblastic cells promote osteoblast differentiation.

7. Gap junctions

Gap junctions permit small water soluble molecules between osteoblast and osteoclast.

8. Paracrine signaling

This type of communication occurs through growth factors, cytokines, chemokines and other small molecules.

Paracrine cell signaling occurs at all stages throughout the process of remodeling via various signaling molecules14. Signals from osteoblasts activate osteoclast For example PTH receptors are present in osteoblast but not in osteoclast. PTH induced osteoclastic bone resorption does not occur in the absence of osteoblast . In low physiological concentration of parathormone and vitamin D3 bone formation occurs whereas in high concentrations it enhance bone resorption. The action of osteoblast and osteoclast is controlled by numerous numbers of cytokines, enzymes, hormone in regulating the bone remodeling.

9. Bone Remodeling

Mechanisms involved in bone remodeling explain the interaction between osteoblast and osteoclast. Bone remodeling occurs in three phases; initiation, transition, and termination.

Table 2. Secretions of bone cells and their effects1,5
Secretions of osteoblast Effects on osteoblast Effects on osteoclast
Proteins Type I collagen Stimulates osteoblast differentiation
Type V collagen Stimulates osteoblast differentiation
Proteoglycans Stimulates osteoblast differentiation
Non- collagenous protein-sialoprotein, osteopontin Inhibits osteoclast activity
Interleukin 1 Stimulate bone resorption
Interleukin 6 Stimulate bone resorption
Interleukin 8 Stimulate bone resorption
Interleukin 11 Stimulate bone resorption
Interleukin 4,13 Stimulates bone formation
Tumour necrosis factor (alfa) Stimulate bone resorption
RANKLigand Stimulates osteoclast differentiation
Osteoprotegrin Inhibits bone resorption
Bone morphogenic protein Stimulates bone formation Inhibits osteoclastogenesi s
Leukotrienes Regulates bone resorption
Prostaglandins Stimulate bone resorption
Monocyte chemoattractant protein-1 Stimulates bone formation
Insulin growth factors Stimulates bone formation
Transforming growth factor Stimulates bone formation TGF-beta inhibits resorption
Platelet derived growth factor Stimulates protein synthesis Favors bone resorption
Fibroblast growth factor Maturation of bone matrix
Cathepsin K Stimulates bone resorption
Ephrin B2 suppresses osteoclast differentiation
OCIL Inhibits osteoblast differentiation
M-CSF Stimulates osteoclast differentiation.
Table 3. Role of bone cells in bone remodeling4
Initiation phase Transition phase Termination phase
Osteoblast Express RANK & activate Wnt signaling
osteoclastogenesis Formation of bone
Produce M-CSF
Osteoclast Formed from osteoclast Liberates coupling factors Differentiation is suppressed
precursors & stimulate differentiation by osteoprotegrin produced
of osteoblast precursors by osteoblasts
Undergo apoptosis
Osteocyte Determines the bone Produce sclerostin which
surface to be resorbed suppresses osteoblastic bone
Bone lining cells Express RANKL &
stimulate RANK on
osteoclast precursors
Final outcome on Resorption of bone Inhibits bone resoption & Continues bone formation
Bone stimulate bone formation

10. Initiation Phase

Initiation phase includes beginning of osteoclastogenesis. Interaction between precursors of osteoclast and the osteoblast cell lineages initiate osteoclastogenesis. Bone lining cells express RANKL & stimulate RANK on osteoclast precursors. Osteocyte determines the surface of bone to be resorbed by osteoclasts. Osteoblasts express RANKL and stimulate osteoclastogenic cascade. It also produces M-CSF reqired for survival of osteoclast lineage cells. Cell migration and cytoskeletal reorganization in macrophages and osteoclasts are controlled by M- CSF. The osteoclastic precursor cell expresses c-Fms, tyrosine kinase receptor for M-CSF. Other inflammatory cytokines like Interleukin 1 Beta, Tumor Necrosis Factor Alfa, Monocyte Chemo attractant Protein Stromal Cell Derived Protein12.

11. Transition Phase

Osteoblastic bone resorption liberates growth factors from bone matrix and activates osteoblastic bone formation. Calcium released from bone during resorption results in apoptosis of osteoclasts. Coupling is an interesting process that takes place in Bone Multicellular Unit (BMU) that determines the transition from bone resorption to bone formation at the cellular level. There are two types of coupling factors; Liberated coupling factors and Secreted coupling factors ( usha kini et al). Based on natalie et al., coupling factors are of four types: a) Matrix developed factors b) Secreted by osteoclasts c) Expressed by osteoclast d) Topographical changes effected by the osteoclast on the bone surface. The membrane bound molecules produced by osteoclast acts on osteoblast precursors to stimulate bone formation. Connexin mediates the gap junction communication between osteoblasts that stimulates osteoblast differentiation and bone formation.

12. Matrix Derived Factor

Bone matrix contains Transforming Growth Factor Beta, Insulin Growth Factor I, II, Platelet Derived Growth Factor, Fibroblast Growth Factor, Tumour Necrosis Factor Alfa, Epidermal Growth Factor etc., which are released from the bone matrix due to resorption (osteoclastic activity). Thus once released remains in the bone micro environment for 5-8 weeks and these factors are readily available for bone formation.

13. Osteoclast Secreted Factors

Osteoclast secretes products to motivate osteoblast precursor cells to differentiate into osteoblast. Based on the study conducted on mice the secretions are cardiotrophin-1, sphingosine-1- phosphate, Wnt 10b, Bone Morphogenic Protein -6 , and complement factor 3a (C3a), cathepsin K inhibitors. These coupling factors are produced by both functional and nonfunctional osteoclasts are also called as anti-resorptive inhibitors. Osteoclast secreted coupling factors like cathepsin K inhibitors are important clinically because they reduce bone resorption without inhibiting bone formation.

14. Osteoclast Membrane Bound Factors

Osteoclast Inhibitory Lectin (OCIL) is a type II trans-membrane c- type lectin that suppresses osteoclast differentiation. Few authors have suggested that osteoclast interacts directly through cell surface regulatory proteins to promote mature osteoblast activity4. EphrinB2 and Semaphorin D are factors proposed for cell to cell contact. Based on the in vitro studies the cell contact dependent mechanisms are considered difficult in bone multicellular unit. If the cell to cell contact takes place it is found in the bone marrow or in the remodeling canopy (an anatomical structure observed above the BMU)14,15.

15. Termination Phase

During termination phase osteoblastic bone formation continues much longer than resorption. Osteoclastic differentiation is suppressed and bone formation is enhanced. Osteoprotegrin is produced by osteoblasts prevents the interaction of RANK with RANK Ligand. Osteoprotegrin activity on osteoclast precursors (RANK) inhibits osteoclastic formation and when osteoprotegrin attacks the mature osteoclast they undergo apoptosis.

Sclerostin is another protein synthesized by osteocytes that suppresses osteoblastic bone formation14,16.

16. Conclusion

Understanding the concept behind osteoblast and osteoclast interaction provides deep understanding of bone pathology, also in treatment and prognosis. The complex interaction of the growth factors, cytokines, enzymes, hormones has significant role in dental therapy. On a gross evaluation of all pathologies of bone reflects an imbalance between osteoblastic and osteoclastic activity. The quantitative and qualitative assessment of bone can be made through the interaction between osteoblast and osteoclast. This is achieved through pathological or laboratory analysis11.


  1. , . Physiology of bone formation, remodeling and metabolism: radionuclide and hybrid bone imaging Springer-Verlag Berlin Heidelberg; .
    [Google Scholar]
  2. . Orban’s oral histology and embryology (13th ed). Reed Elsevier India Private Limited; .
    [Google Scholar]
  3. . Ten cate’s oral histology, development, structure and function. 2008:92-121.
    [Google Scholar]
  4. , . Osteoclast–osteoblast communication. Archives of Biochemistry and Biophysics;. :160-8582.
    [Google Scholar]
  5. . Regulation of bone resorption and mineral homeostasis by osteocytes. IBMS Bone key. 2009;6(2):63-70.
    [Google Scholar]
  6. , . Bone disease in primary hyper-parathyroidism. Arq Bras Endocrinol Metabol. 2014;58(5):553-61.
    [Google Scholar]
  7. , , , , . Three dimensional reconstruction of chick calvarial osteocytes and their cell processes using confocal microscopy. Bone Pubmed. 2005;36(5):877-83.
    [Google Scholar]
  8. , , . Buried alive: How osteo-blasts become osteocytes. Developmental Dynamics. 2006;235:176-90.
    [Google Scholar]
  9. . A three dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos. Cell Tissue Research. 1986;246:125-31.
    [Google Scholar]
  10. , , , . Evidence of the role of osteocytes in the initiation of targeted remodeling: Technology and Healthcare. . 2009;17:49-56.
    [Google Scholar]
  11. , , . Osteoclast formation and differentiation: An overview. J Med Dent Sci. 2012;59:65-74.
    [Google Scholar]
  12. , , , . The cell biology of osteoclast function. Journal of Cell Science. 2000;113:377-81.
    [Google Scholar]
  13. , . Disorders of bone remodeling. Annu Rev Pathol, PMC. 2013;6:121-45. 10.1146
    [Google Scholar]
  14. , . Coupling signals between the osteoclast and osteoblast: How are messages transmitted between these temporary visitors to the bone surface. J Biol Chem. 2010;285(33):25103-8.
    [Google Scholar]
  15. , , . Osteoclasts have Multiple Roles in bone in addition to bone resorption. Crit Rev Eukaryot Gene Expr, PMC. 2010;19(3):171-80.
    [Google Scholar]
  16. , , . Formation of osteoclast-like cells from peripheral blood of periodontitis patients occur without supplementation of macrophage colony stimulating factor. J Clin Periodontol. 2008;35:568-75.
    [Google Scholar]
Show Sections